Low urine calcium excretion in African American patients with primary hyperparathyroidism

Endocrine Practice

Volumn 17, Issue 6, 2011, Pages 867-872

  Taha, Wael ^a   Singh, Neelima ^a   Flack, John ^a   Abou Samra, Abdul ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CREATININE; PARATHYROID HORMONE;

ADULT; AFRICAN AMERICAN; ARTICLE; BODY MASS; CALCIUM EXCRETION; CALCIUM URINE LEVEL; CREATININE URINE LEVEL; FAMILIAL HYPOCALCIURIC HYPERCALCEMIA; GLOMERULUS FILTRATION RATE; HUMAN; HYPERCALCEMIA; MAJOR CLINICAL STUDY; PARATHYROID HORMONE BLOOD LEVEL; PATIENT SATISFACTION; PREVALENCE; PRIMARY HYPERPARATHYROIDISM;

EID: 84855860631     PISSN: 1530891X     EISSN: 19342403     Source Type: Journal    
DOI: 10.4158/EP11022.OR     Document Type: Article

References (27)

1. Bringhurst F, Demay M, Kronenberg H. Hormones and disorders of mineral metabolism. In: Kronenberg H, Melmed S, Polonsky K, Larsen P, eds. Williams Textbook of Endocrinology. 11th ed. Philadelphia, PA: Saunders Elsevier, 2008: 1203-1223.
2. Kearns AE, Thompson GB. Medical and surgical manage-ment of hyperparathyroidism. Mayo Clin Proc. 2002;77: 87-91.
3. Bilezikian JP, Khan AA, Potts JT Jr. Guidelines for the management of asymptomatic primary hyperparathyroid-ism: summary statement from the third international work-shop. J Clin Endocrinol Metab. 2009;94:335-339.
4. Marx SJ, Attie MF, Levine MA, Spiegel AM, Downs RW Jr, Lasker RD. The hypocalciuric or benign variant of familial hypercalcemia: clinical and biochemical features in ffteen kindreds. Medicine (Baltimore). 1981;60:397-412. (Pubitemid 12207234)
5. Law WM Jr, Heath H III. Familial benign hypercalcemia (hypocalciuric hypercalcemia): clinical and pathogenetic studies in 21 families. Ann Intern Med. 1985;102:511-519.
6. Brown EM. Familial hypocalciuric hypercalcemia and other disorders with resistance to extracellular calcium. Endocrinol Metab Clin North Am. 2000;29:503-522.
7. Pollak MR, Brown EM, Chou YH, et al. Mutations in the human Ca(2+)-sensing receptor gene cause familial hypo-calciuric hypercalcemia and neonatal severe hyperparathy-roidism. Cell. 1993;75:1297-1303.
8. Brown EM, Pollak M, Hebert SC. The extracellular cal-cium-sensing receptor: its role in health and disease. Annu Rev Med. 1998;49:15-29. (Pubitemid 28197438)
9. Riccardi D, Brown EM. Physiology and pathophysiology of the calcium-sensing receptor in the kidney. Am J Physiol Renal Physiol. 2009;298:F485-F499.
10. Adams PH. Conservative management of primary hyper-parathyroidism. J R Coll Physicians Lond. 1982;16:184-190.
11. Yonemura K, Hishida A. Familial hypocalciuric hypercal-cemia. Intern Med. 2002;41:1084-1085.
12. Kassem M, Eriksen EF, Mosekilde L. Familial hypocalci-uric hypercalcemia [in Danish]. Nord Med. 1991;106:107-108, 111.
13. Marx SJ, Spiegel AM, Brown EM, et al. Divalent cation metabolism: familial hypocalciuric hypercalcemia versus typical primary hyperparathyroidism. Am J Med. 1978;65: 235-242. (Pubitemid 8392382)
14. Bell NH, Yergey AL, Vieira NE, Oexmann MJ, Shary JR. Demonstration of a difference in urinary calcium, not calcium absorption, in black and white adolescents. J Bone Miner Res. 1993;8:1111-1115. (Pubitemid 23261105)
15. Bikle DD, Ettinger B, Sidney S, Tekawa IS, Tolan K. Differences in calcium metabolism between black and white men and women. Miner Electrolyte Metab. 1999;25: 178-184. (Pubitemid 29339752)
16. Bryant RJ, Wastney ME, Martin BR, et al. Racial differ-ences in bone turnover and calcium metabolism in adoles-cent females. J Clin Endocrinol Metab. 2003;88:1043-1047. (Pubitemid 36337754)
17. Ettinger B, Sidney S, Cummings SR, et al. Racial dif-ferences in bone density between young adult black and white subjects persist after adjustment for anthropometric, lifestyle, and biochemical differences. J Clin Endocrinol Metab. 1997;82:429-434. (Pubitemid 27068606)
18. Kleerekoper M, Nelson DA, Peterson EL, et al. Reference data for bone mass, calciotropic hormones, and biochemical markers of bone remodeling in older (55-75) postmenopausal white and black women. J Bone Miner Res. 1994;9:1267-1276. (Pubitemid 24238358)
19. Eastell R, Arnold A, Brandi ML, et al. Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab. 2009;94:340-350.
20. Weber CJ, Sewell CW, McGarity WC. Persistent and recurrent sporadic primary hyperparathyroidism: histopa-thology, complications, and results of reoperation. Surgery. 1994;116:991-998. (Pubitemid 24382156)
21. Hinnie J, Bell E, McKillop E, Gallacher S. The preva-lence of familial hypocalciuric hypercalcemia. Calcif Tissue Int. 2001;68:216-218.
22. Bussey AD, Bruder JM. Urinary calcium excretion in pri-mary hyperparathyroidism: relationship to 25-hydroxyvita-min D status. Endocr Pract. 2005;11:37-42. (Pubitemid 43073088)
23. Penniston KL, Jones AN, Nakada SY, Hansen KE. Vitamin D repletion does not alter urinary calcium excre-tion in healthy postmenopausal women. BJU Int. 2009;104: 1512-1516.
24. Lambers TT, Bindels RJ, Hoenderop JG. Coordinated control of renal Ca2+ handling. Kidney Int. 2006;69: 650-654. (Pubitemid 43237632)
25. Cosman F, Morgan DC, Nieves JW, et al. Resistance to bone resorbing effects of PTH in black women. J Bone Miner Res. 1997;12:958-966. (Pubitemid 27225007)
26. Bell NH, Greene A, Epstein S, Oexmann MJ, Shaw S, Shary J. Evidence for alteration of the vitamin D-endocrine system in blacks. J Clin Invest. 1985;76:470-473. (Pubitemid 15227507)
27. Taylor EN, Curhan GC. Differences in 24-hour urine composition between black and white women. J Am Soc Nephrol. 2007;18:654-659 (Pubitemid 46193332)